Semiglazov Vf

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer et al. · Annals of Oncology · 2017 · 1.3K citations · Full text

Medicine, Oncology, Breast Oncology +12

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

W. Eiermann, Stefan Paepke, Justus Appfelstaedt et al. · Annals of Oncology · 2001 · 716 citations

Medicine, Oncology, Pharmacotherapy +10

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

Luca Gianni, Chiun‐Sheng Huang, Daniel Egle et al. · Annals of Oncology · 2022 · 386 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer

Semiglazov Vf, Semiglazov Vf, G. A. Dashyan et al. · Cancer · 2007 · 330 citations · Full text

Medicine, Endocrinology, Oncology +15